S5 Ep43: Dietrich Details Data and Future Research With Immunotherapy in Stage III NSCLC
OncLive® On Air - Een podcast door OncLive® On Air
Dr. Dietrich discusses the latest developments with immunotherapy and targeted therapy in stage III non–small cell lung cancer.
